MaaT Pharma:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MaaT Pharma - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10977
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota – dysbiosis related diseases. The company focuses on developing MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovative device for stool collection and storage. It also develops therapies based on micro biotherapy and it envisages therapeutic applications for patients with leukemia and bone and joint infections whose treatment contributes to the treatment of dysbiosis. The company also develops treatment for infectious diseases related to onco-hematology in fragile patients. MaaT is headquartered in Lyon, France.

MaaT Pharma – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MaaT Pharma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MaaT Pharma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MaaT Pharma, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
MaaT Pharma Raises USD11 Million in Series A Financing 10
MaaT Pharma Raises USD1 Million in Second Round of Venture Financing 11
MaaT Pharma Raises USD1.2 Million in Seed Financing 12
Partnerships 13
MaaT Pharma Enters into Agreement with Biocodex 13
MaaT Pharma and Bioaster Enter into Co-Development Agreement 14
Licensing Agreements 15
MaaT Pharma Enters into Licensing Agreement with SATT Lutech 15
MaaT Pharma – Key Competitors 16
MaaT Pharma – Key Employees 17
MaaT Pharma – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Clinical Trials 19
Mar 05, 2018: MaaT Pharma Launches European Clinical Trial in Severe Acute Graft-versus-Host Disease for patients receiving allogeneic Hematopoietic Stem Cell Transplantation 19
Jul 20, 2017: MaaT Pharma completes patient recruitment of its Odyssée clinical trial 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
MaaT Pharma, Pharmaceuticals & Healthcare, Key Facts 2
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MaaT Pharma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MaaT Pharma, Deals By Therapy Area, 2012 to YTD 2018 8
MaaT Pharma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MaaT Pharma Raises USD11 Million in Series A Financing 10
MaaT Pharma Raises USD1 Million in Second Round of Venture Financing 11
MaaT Pharma Raises USD1.2 Million in Seed Financing 12
MaaT Pharma Enters into Agreement with Biocodex 13
MaaT Pharma and Bioaster Enter into Co-Development Agreement 14
MaaT Pharma Enters into Licensing Agreement with SATT Lutech 15
MaaT Pharma, Key Competitors 16
MaaT Pharma, Key Employees 17

List of Figures
MaaT Pharma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MaaT Pharma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MaaT Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[MaaT Pharma:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rajesh Exports Limited
    Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report Summary Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ingram Micro Inc:企業の戦略的SWOT分析
    Ingram Micro Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Willis Lease Finance Corp (WLFC)
    Willis Lease Finance Corp (WLFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Fred’s Inc:企業の戦略・SWOT・財務情報
    Fred's Inc - Strategy, SWOT and Corporate Finance Report Summary Fred's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Berkem SA:企業の戦略・SWOT・財務情報
    Berkem SA - Strategy, SWOT and Corporate Finance Report Summary Berkem SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • MIS Implants Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary MIS Implants Technologies Ltd (MIS) is a medical device company that offers advanced products and solutions for dental implantology treatment. The company offers dental implants, tools and kits, superstructures, and solutions for oral restoration and health, among others. Its implants compri …
  • Mundipharma International Ltd:企業の戦略的SWOT分析
    Mundipharma International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Elips Versicherungen AG:企業の戦略的SWOT分析
    Elips Versicherungen AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • CellProthera-製薬・医療分野:企業M&A・提携分析
    Summary CellProthera (CellProthera) focuses on the development of therapeutic solutions for the regeneration of organs which are damaged by disease or trauma from autologous blood peripheral stem cells. The company’s lead candidate ProtheraCytes, is an advanced therapy medicinal product within tissu …
  • Asia Commercial Joint Stock Bank:企業の戦略・SWOT・財務情報
    Asia Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report Summary Asia Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Nelnet, Inc.:企業の戦略・SWOT・財務情報
    Nelnet, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nelnet, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Breas Medical AB:医療機器:M&Aディール及び事業提携情報
    Summary Breas Medical AB (Breas), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co Ltd, is a medical device company that manufactures and markets medical devices for anesthesia and respiratory markets. The company provides isleep and vivo products. It provides products such as isleep, vivo 3 …
  • Lagardere SCA:企業のM&A・事業提携・投資動向
    Lagardere SCA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lagardere SCA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Novelis Inc
    Novelis Inc - Strategy, SWOT and Corporate Finance Report Summary Novelis Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Bashneft (BANE)-石油・ガス分野:企業M&A・提携分析
    Summary Bashneft is a vertically integrated oil and gas company. It operates in the oil and gas production, refining, petrochemical production, marketing and distribution of oil and petroleum products. It sales crude oil, petroleum products and petrochemical products to the domestic market. The comp …
  • Deutsche Telekom AG:戦略・SWOT・企業財務分析
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hal Trust:企業の戦略・SWOT・財務分析
    Hal Trust - Strategy, SWOT and Corporate Finance Report Summary Hal Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • The Beacon Insurance Company Limited:企業の戦略・SWOT・財務分析
    The Beacon Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Beacon Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Aquinox Pharmaceuticals Inc (AQXP):企業の財務・戦略的SWOT分析
    Summary Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The company's lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a …
  • TBC Insurance JSC:企業の戦略的SWOT分析
    TBC Insurance JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆